Takeda to Pay Insilico up to $600 million for AI Platform

Key Takeaways

• AI token prices have dropped 20% from their May high, potentially impacting AI companies' pricing power.
• Takeda Pharmaceutical has agreed to pay Insilico Medicine up to $600 million to use its AI platform for drug discovery.
• Robinhood is launching AI-powered trading tools for retail investors.
• The global AI training dataset market is expected to reach $49.82 billion by 2031.
• Intercontinental Exchange plans to launch GPU compute futures contracts.
• AI-related stocks have delivered significant returns for A-share investors in the first half of 2026.
• The AI sector's pricing power is being questioned as token prices collapse by over 90% since 2023.
• Total AI spend has roughly doubled since last year despite a 20% drop in the Silicon Data LLM Token Expenditure Index.
• HSBC analyst Kevin Wang believes Micron's strong earnings beat driven by AI demand will continue to drive the stock price higher.
• Achieve Partners is addressing the AI talent gap through apprenticeships.

AI Sector Losing Key Signal as Token Prices Drop

The AI sector is facing uncertainty as token prices for AI usage drop by 20% from their May high. The Silicon Data LLM Token Expenditure Index, which tracks AI token prices, has nearly doubled since its inception in December. This trend may indicate that AI companies are losing pricing power, making it harder for them to justify high investments. The sector's future growth may be impacted by increasing cost sensitivity among customers.

AI Pricing Power Looks Fragile as Token Prices Collapse

The AI sector's pricing power is being questioned as token prices collapse by over 90% since 2023. Despite a 20% drop in the Silicon Data LLM Token Expenditure Index, total AI spend has roughly doubled since last year. The trend has sparked concerns that AI companies may struggle to maintain profitability. Regulatory pressures and increasing competition may also impact the sector's growth.

Takeda and Insilico Strike $600 Million AI Drug Deal

Takeda Pharmaceutical has agreed to pay Insilico Medicine up to $600 million to use its AI platform for drug discovery. The deal marks a significant expansion of Takeda's use of AI in drug discovery and is a major win for Insilico. The partnership will focus on identifying drug candidates that meet predefined scientific and early development criteria.

Takeda and Insilico Partner for AI-Powered Drug Discovery

Takeda has entered a strategic collaboration with Insilico Medicine to use AI in early-stage drug discovery. The deal includes up to $600 million in project initiation fees, near-term payments, and milestones. Insilico's Pharma.AI platform will support biological target identification, molecular design, and clinical trial prediction.

Morgan Stanley: AI-Related Stocks Leading Market Gains

Morgan Stanley's chief China equity strategist, Laura Wang, believes that China is a crucial component of the global AI super cycle. AI-related stocks have delivered significant returns for A-share investors in the first half of 2026. Wang's comments highlight the growing importance of AI in the Chinese market.

Achieve Partners Addresses AI Talent Gap with Apprenticeship

Achieve Partners' Daniel Pianko discusses the firm's strategy to address the AI talent gap through apprenticeships. The approach aims to equip portfolio companies with the necessary AI talent to drive innovation.

AI Makes Devices More Expensive

The increasing demand for AI-powered devices and services has led to a 15% rise in costs over the past year. As a result, consumers are facing higher prices for devices and services. The trend is expected to continue as AI becomes more prevalent in daily life.

Intercontinental Exchange to Launch GPU Compute Futures

Intercontinental Exchange plans to launch GPU compute futures contracts in partnership with NATIVX. The new contracts will create a regulated market for trading AI compute power, allowing companies to hedge against potential price fluctuations.

Robinhood to Empower Retail Investors with AI Trading Tools

Robinhood CEO Vlad Tenev aims to provide retail investors with AI-powered trading tools similar to those used by institutional investors. The company's agentic AI trading offerings will enable users to automate trades and make purchases.

Global AI Training Dataset Market to Reach $49.82 Billion

The global AI training dataset market is expected to reach $49.82 billion by 2031, growing at a CAGR of 34.4%. The market is driven by increasing adoption of AI technologies across various industries.

HSBC Backs Micron, Citing Strong AI Demand

HSBC analyst Kevin Wang believes Micron's strong earnings beat driven by AI demand will continue to drive the stock price higher. The analyst has a buy rating on Micron with a price target of $70.

Sources

• The AI Trade Is Losing One of Its Key Signals
• With token prices collapsing and regulation rising, AI’s pricing power looks fragile
• Takeda, InSilico Strike AI Drug-Discovery Deal Worth Up to $600 Million
• Takeda signs US$600M AI drug discovery deal with Insilico
• BizTalk special on China market outlook | Morgan Stanley: AI-related stocks leading market gains
• The Apprenticeship Returns to Fill the AI Talent Gap
• Here's how much more expensive your devices have gotten thanks to AI
• Intercontinental Exchange (ICE) Plans GPU Compute Futures With NATIVX To Trade AI Power
• Vlad Tenev Says Robinhood Wants Retail Investors To Trade Like The Pros With AI — Mizuho Calls HOOD The ‘AWS’ Of Online Brokers
• Global AI Training Dataset Market to Hit $49.82 Billion by 2031: Key Growth Drivers and Insights
• HSBC Delivers Bullish AI Verdict After Micron Earnings Surprise